Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Cnx-2006 | 1375465-09-0 | MFCD26142654 | 98.4% | C26H27F4N7O2 | 10MG
Supplier: Medchemexpress LLC HY1389710MG
CNX-2006 is a mutant-selective, irreversible epidermal growth factor receptor (EGFR) inhibitor with potent activity against the EGFRT790M mutant (IC50 ≈ 20 nM). It is supplied for research use as a solid and in DMSO solutions, and selectively inhibits growth of EGFR-T790M cells versus wild-type EGFR.
- Potent mutant-selective EGFR inhibition (EGFRT790M IC50 ≈ 20 nM).
- Irreversible mechanism of action.
- Shows activity against uncommon EGFR mutations including G719S, L861Q, exon 19 insertion, and T854A.
- Available as a white to gray solid and as DMSO solution for assays.
- High purity suitable for research applications (≈98.4%).
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?